Pharmaceutical Executive
Pharmaceutical Executive: April 2023
Volume: 43
Issue: 4
Pharmaceutical Executive: March 2023
Volume: 43
Issue: 3
Pharmaceutical Executive: February 2023
Volume: 43
Issue: 02
Pharmaceutical Executive: January 2023
Volume: 43
Issue: 01
Pharmaceutical Executive-12-01-2022
Volume: 42
Issue: 12
Pharmaceutical Executive-11-01-2022
Volume: 42
Issue: 11
Pharmaceutical Executive-10-01-2022 APEX Awards Program
Pharmaceutical Executive-10-01-2022
Volume: 42
Issue: 10
Pharmaceutical Executive-09-01-2022
Volume: 42
Issue: 9
Pharmaceutical Executive-08-01-2022
Volume: 42
Issue: 8
Pharmaceutical Executive-07-01-2022
Volume: 42
Issue: 7
Pharmaceutical Executive-06-01-2022
Volume: 42
Issue: 6
Pharmaceutical Executive-05-01-2022
Volume: 42
Issue: 5
Pharmaceutical Executive-04-01-2022
Volume: 42
Issue: 4
Pharmaceutical Executive-03-01-2022
Volume: 42
Issue: 3
Pharmaceutical Executive-02-01-2022
Volume: 42
Issue: 2
Pharmaceutical Executive-01-01-2022
Volume: 42
Issue: 1
Pharmaceutical Executive-12-01-2021
Volume: 41
Issue: 12
Pharmaceutical Executive-11-01-2021
Volume: 41
Issue: 11
Pharmaceutical Executive-10-01-2021
Volume: 41
Issue: 10
Pharmaceutical Executive-09-01-2021
Volume: 41
Issue: 9
Pharmaceutical Executive-08-01-2021
Volume: 41
Issue: 8
Pharmaceutical Executive-07-01-2021
Volume: 41
Issue: 7
Pharmaceutical Executive-06-01-2021
Volume: 41
Issue: 6
Pharmaceutical Executive-05-01-2021
Volume: 41
Issue: 5
Pharmaceutical Executive-04-01-2021
Volume: 41
Issue: 4
Pharmaceutical Executive-03-01-2021
Volume: 41
Issue: 3
Pharmaceutical Executive-02-01-2021
Volume: 41
Issue: 2
Pharmaceutical Executive-01-01-2021
Volume: 41
Issue: 1
Pharmaceutical Executive-12-01-2020
Volume: 40
Issue: 12
Advertisement
Advertisement
Trending on PharmExec
1
Aradhana Sarin: The CFO as a Catalyst
2
Regeneron Enters $2.1 Billion Radiopharma Collaboration with Telix Pharmaceuticals
3
Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment
4
FDA Issues CRL to Replimune for RP1 Biologics License Application for Advanced Melanoma Treatment
5